Ana García-Sangenís

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The purpose of this study was to characterize the profile of patients with non-valvular atrial fibrillation who start an anticoagulant treatment after diagnosis with dabigatran and compare it with those who start with vitamin K antagonists (VKAs). We analysed primary health care-based electronic health records data from 15,075 people with new diagnosis of(More)
  • 1